Do vitamins halt the COVID-19-evoked pro-inflammatory cytokines involved in the development of neuropathic pain? - 20/07/25
, Nariman Essmat a, b, 1, Imre Boldizsár a, b, 1, Bence Tamás Varga a, b, Yashar Chalabiani a, b, Sarah Kadhim Abbood a, b, Aliz Judit Ernyey a, b, Kornél Király a, b, Attila Máté a, b, Pál Riba a, b, Julia Timár a, István Gyertyán a, b, Ildikó Miklya a, b, Carmela Parenti c, Lorella Pasquinucci c, Bence Ágg a, b, e, Susanna Fürst a, b, Péter Ferdinandy a, b, e, E. Sylvester Vizi a, d, Laszlo G. Harsing a, b
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.
Artículo gratuito.
Conéctese para beneficiarse!
Abstract |
Neuropathic pain (NP), a disease affecting the somatosensory nervous system, causes a high socioeconomic burden on healthcare systems and society; yet, its management has not been fully solved. Post COVID-19, with sequelae of the somatosensory system, further increases the number of individuals with chronic pain, thus further exacerbating the social burden related to NP. The pro-inflammatory mediators, such as TNF-α, IL-1β, and IL-6, are massively released in patients with COVID-19 and are known to be involved in the pathomechanisms of NP, particularly in relation to neuronal sensitization. Specifically, the release of large amounts of these pro-inflammatory cytokines from immune and non-immune effector cells during the acute and post COVID-19 phases prone to have substantial involvement in the development of post COVID-19 NP. Several preclinical and clinical studies have shown that vitamins’ supplementation, namely vitamins A, B1, B2, B3, B5, B6, B7, B9, B12, C, D, E, and K can attenuate the enhanced release of TNF-α, IL-1β, and IL-6. The early supplementation of these vitamins may mitigate the neuronal sensitization evoked by cytokine storm due to COVID-19 or other viruses. This strategy may provide a novel approach to prevent the development of post COVID-19 NP. This review highlights the mechanisms by which COVID-19 can induce NP and how vitamins may help to alleviate these post COVID-19 sequelae.
El texto completo de este artículo está disponible en PDF.Graphical Abstract |
Highlights |
• | Post COVID-19 NP has been documented in certain individuals following infection with SARS-CoV-2. |
• | An overlap exists between COVID-19 and NP concerning pro-inflammatory mediators, specifically TNF-α, IL-1β, and IL-6. |
• | Vitamins can mitigate the release of pro-inflammatory mediators, specifically TNF-α, IL-1β, and IL-6. |
• | Vitamins, alone or as part of a comprehensive prophylactic or treatment strategy, present promising results in the context of post COVID-19 NP. |
Abbreviations : ACC1 and 2, ACE2R, ACP, Acsl, ADS, AMPA, AMPARs, APP, ARDS, ASC, ATP, C1q, CAT, CCI, CCL2, CD4+ T cells, CD8+ T cells, CFA, CGRP, CNS, CoA, CoQ10, COVID-19, COX-2, CPT1, CRP, CSF, CSSE, CX3CR1, Cx43, CXCL1, DN, DII, DMK, DNA, DRG, EFSA, EGF, EPSCs, ERK, ERK1/2, E-utilities, FAD, FMN, GABA, GAS6, GLT-1, GM-CSF, GML, GPCR, GRK2, HCoV-229E, HLMECs, HTTP, ICAM-1, IASP, ICD-11, ICU, IFNβ, IFNγ, IL-1α, IL-1β, IL-1, IL-2, IL-4, IL-5, IL-6, IL-8, IL-10, IL-12, IL-13, IL-17, IL-23, IL-33, IL1RL1, INOS, IPSCs, IU, JNKs, KCAT, LANSS, LPS, MAPK, MCP-1, M-CSF, MERS-CoV, MK-n, MMPs, MRNA, MTORC1, NAD, NADPH, NAM, NAMPT, NaV, NFL, NFs, NF-κB, NLRP3, NMDA, NMDAR, NMN, NO, NP, NR, ORF, PARP, PASC, PCR, PD, PLP, PMP, PNP, PNI, PNS, PPARγ, PROS1, PS1, PLP, RCTs, RdRp, ROS, RTKs, S protein, SARM1, SARS-CoV-2, SEPSCs, SGCs, SIPSCs, Sirtuins, S-LANSS, SNI, SNRIs, SP, SSR, T cells, TCA cycle, TCAs, TGFβ, Th1 cells, Th2 cells, TIR, TLR3 -TRIF-IRF3, TLRs, TNFR1, TNF-α, Trp, TRPA1, TRPV1, TYRO3, WHO
Keywords : Severe acute respiratory syndrome coronavirus-2, Pro-inflammatory mediators, Peripheral and central sensitization, Neuropathic pain, Post COVID-19, Vitamins
Esquema
Vol 189
Artículo 118346- août 2025 Regresar al número
Artículo precedente
- Mitochondrial homeostasis: Exploring their impact on skin disease pathogenesis
- Hajar Ahmad Jamil, Norwahidah Abdul Karim
- The H2S-donor Erucin modulates SIRT1 and rescues obesity-induced vascular dysfunction in human vessels
- Era Gorica, Eugenia Piragine, Alessandro Mengozzi, Federica Cappelli, Emiliano Duranti, Stefano Masi, Agostino Virdis, Lara Testai, Eleonora Pagnotta, Laura Righetti, Sarah Costantino, Francesco Paneni, Vincenzo Calderone, Alma Martelli
Bienvenido a EM-consulte, la referencia de los profesionales de la salud.